L-163,491
L-163,491 is a drug which acts as a partial agonist of angiotensin II receptor type 1, and with lower affinity as an agonist of angiotensin II receptor type 2, mimicking the action of angiotensin II. Its practical applications to date have been limited to scientific research into the function of the angiotensin receptor system, but it has been suggested as a potential therapeutic agent for the treatment of inflammation of the lungs associated with certain viral diseases such as COVID-19.
Q770260
partial agonist
Concept
Q15332826
angiotensin II receptor type 1
UNK
Q17816212
angiotensin II receptor type 2
Concept
Q65963433
angiotensin II
Concept
Q344873
inflammation of the lungs
Concept
Q84263196
COVID-19
Concept
Q96386512
L-163,491
UNK
-163.491^^http://www.w3.org/2001/XMLSchema#decimal
-163,491
NUMBER
+1^^http://www.w3.org/2001/XMLSchema#decimal
1
NUMBER
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
has cause